Spartan Medical adds ViaCLYR wound irrigation to federal ECAT

Spartan Medical has added Clyra Medical’s ViaCLYR advanced wound irrigation solution to the Defense Logistics Agency Electronic Catalog for government healthcare facilities. The move broadens federal access to an FDA-cleared wound cleansing product that Clyra says offers faster, longer-lasting antimicrobial protection than standard solutions.

Why it matters: - The ECAT addition expands federal buying access to a wound care product for VA, Defense Department, Bureau of Prisons, Indian Health Service and other federal healthcare sites. - Spartan Medical will be the exclusive purchaser of ViaCLYR products from Clyra for resale to those facilities. - The agreement also covers certain civilian hospitals operating under VA Community Care or VA-funded contracts.

What happened: - Spartan Medical announced the addition of Clyra Medical Technology’s ViaCLYR advanced wound irrigation solution to the Defense Logistics Agency Electronic Catalog. - The announcement was made Sept. 15, 2026. - Spartan Medical is a service-disabled, veteran-owned and U.S.-operated government contractor. - Clyra Medical Technologies is the developer of ViaCLYR.

The details: - ViaCLYR is powered by Clyrasept Copper-Iodine Complex Solution technology. - Clyra describes the technology as a broad-spectrum antimicrobial designed around four wound-care priorities: speed, efficacy, persistence and biocompatibility. - ViaCLYR has been shown to kill 99.99% of 18 pathogens within one minute, including MRSA, VRE and Candida auris. - The product requires no rinsing and provides 72-hour antimicrobial management without reapplication. - ViaCLYR remains non-cytotoxic. - Standard wound care solutions can kill quickly but persist for 60 seconds or less and require repeated reapplication and dressing changes. - ViaCLYR is FDA 510(k)-cleared for cleansing, irrigating and debriding first- and second-degree burns, Stage I-IV pressure ulcers, diabetic and stasis ulcers, post-surgical wounds and abrasions. - The product is also cleared for moistening and lubricating absorbent wound dressings. - Spartan Medical said the product is priced at parity with standard solutions while offering stronger performance.

Between the lines: - The deal gives Clyra a new federal distribution path at a time when wound care and infection control remain high-priority issues across government facilities. - The exclusive resale structure suggests Spartan Medical will control much of the federal purchasing channel for ViaCLYR. - Clyra framed the product as a way to reduce dressing changes, time and costs, while potentially limiting disruption to healing.

What's next: - Government facilities that buy through ECAT can now order ViaCLYR under the Spartan Medical contract. - Spartan Medical says customers can contact its service team for ordering, specifications or more information at cs@spartanmedical.com or 888-240-8091. - Spartan Medical also provided its LinkedIn and YouTube pages for updates.

The bottom line: - ViaCLYR is now positioned for wider federal use as a cleared wound irrigation option with antimicrobial persistence that Clyra says outlasts standard solutions.